Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Record Maintenance of IPC Results – V 2.0

Posted on By

Elixir Department: SOP for Record Maintenance of IPC Results – V 2.0

Standard Operating Procedure for Record Maintenance of In-Process Control (IPC) Results

Department Elixir Department
SOP No. SOP/ELX/207/2025
Supersedes SOP/ELX/207/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a systematic approach for accurate, complete, and compliant documentation of In-Process Control (IPC) test results during the manufacturing of elixirs. This ensures traceability, supports batch release, and maintains regulatory compliance.

2. Scope

This SOP applies to all IPC records generated during elixir manufacturing, including physical, chemical, and microbiological test results conducted by QC and production personnel. It includes both manual and electronic records.

3. Responsibilities

  • Production Operator:
    • Record basic IPC parameters in Batch Manufacturing Record (BMR).
  • QC Analyst:
    • Document all IPC observations and test results in the IPC Logbook and validate against specification.
  • QA Officer:
    • Verify IPC records for completeness and compliance.
See also  Elixir Department: SOP for CIP Validation of Mixing Equipment - V 2.0

4. Accountability

The QC Head is accountable for maintaining IPC records. The QA Head ensures review and compliance with Good Documentation Practices (GDP) and regulatory standards.

5. Procedure

5.1 Recording of IPC Results

  1. All IPC results must be entered:
    • In the IPC Logbook (Annexure-1)
    • In the relevant section of the Batch Manufacturing Record (BMR)
    • In electronic systems where applicable (with audit trail)
  2. Ensure entries are made immediately after each test or observation.
  3. Each entry must include:
    • Date and time of test
    • Test parameter (e.g., pH, viscosity, weight per mL, API content)
    • Observed result
    • Specification limit
    • Initials of analyst

5.2 Correction of Entries

  1. Do not overwrite, scratch, or erase any data.
  2. Strike through the incorrect entry with a single line, write the correct value next to it, and sign with date and reason.
See also  Elixir Department: SOP for Labeling of Raw Materials During Dispensing - V 2.0

5.3 Retention of Records

  1. All IPC records shall be retained for a minimum of 5 years or as per regulatory guidelines.
  2. Electronic data must be backed up daily and protected with access control and audit trails.

5.4 Review and Approval

  1. QA must review IPC results during batch record review before product release.
  2. Any Out-of-Specification (OOS) result must be investigated and documented as per SOP/QC/OOS/001.

5.5 Electronic System Requirements (if applicable)

  1. System must comply with 21 CFR Part 11 and include:
    • User authentication and access rights
    • Audit trails for all modifications
    • Electronic signatures

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • GDP: Good Documentation Practices
  • OOS: Out-of-Specification
See also  Elixir Department: SOP for Operation of Filter Press - V 2.0

7. Documents

  1. IPC Logbook (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. Deviation Report (if applicable)

8. References

  • WHO TRS 996 – Annex 3: GMP for Pharmaceuticals
  • 21 CFR Part 211.180 – Records and Reports
  • ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Logbook

Date Batch No. Test Parameter Result Specification Initials QA Verified
11/04/2025 ELX-0425-025 pH 6.8 6.5–7.0 Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Added provisions for electronic record-keeping Data Integrity Compliance QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Site Procedures Conflict with Central SOPs: Audit Risk from Inconsistent Documentation
Next Post: Analytical Method Development: SOP for Moisture Content Testing in Powder Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version